PKN3 actif, humain étiqueté GST, PRECISIO Kinase, recombinant, exprimé en cellules baculovirus infectées Sf9 ,>=70% (SDS-PAGE), solution de glycérol aqueuse tamponnée

Code: srp5229-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

PKN3 or PRK3 is a serine/threonine protein kinase which can associate with RHOA in a GTP-dependent manner. PKN3 can also interact with GRAF and GRAF2 via ...


en savoir plus

Votre prix
$566.47 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

PKN3 or PRK3 is a serine/threonine protein kinase which can associate with RHOA in a GTP-dependent manner. PKN3 can also interact with GRAF and GRAF2 via the SH3 domains and phosphorylate these proteins. PKN3 is a mediator of malignant growth of human prostate cancer cells and functions downstream of activated PI3K. PKN3 is upregulated in human tumor cells but not in surrounding nontumorigenic tissues. Inducible knockdown of PKN3 expression inhibited metastasis in a mouse prostate tumor model.

Legal Information

PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC

Physical form

Supplied in 50mM Tris-HCl, pH 7.5, 150mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25mM DTT, 0.1mM PMSF, 25% glycerol.

Preparation Note

after opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles

assay≥70% (SDS-PAGE)
formbuffered aqueous glycerol solution
Gene Informationhuman ... PKN3(29941)
mol wt~130 kDa
NCBI accession no.NM_013355
product linePRECISIO® Kinase
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
specific activity2.5-3.5 nmol/min·mg
storage temp.−70°C
Ce produit répond aux critères suivants: